Desktop header image. Mobile header image.

One world against COVID-19. A global effort for

The Covid-19 pandemic cost the global economy an estimated 28 trillion US dollars in lost output in 2020

Thanks to the Advance Market Commitment, 92 lower & middle-income countries will have access to safe and effective vaccines.

Every 1 dollar invested in ensuring equitable access to vaccines will generate 12 dollars in the global economy in the medium term

IMF, GAVI and Bill & Melinda Gates Foundation

Dr Tedros Adhanom Ghebreyesus

“Vaccinating equitably will save lives, stabilise health systems and drive a truly global recovery.”

Dr Tedros Adhanom Ghebreyesus, Director General World Health Organisation

Equitable access and Covid-19

No country is safe until we are all safe

vaccine bottle

Covid-19 has no regard for national borders. Throughout the world, lives have been lost, livelihoods destroyed as societies across the world have battled against the virus.

No country or company can go it alone. We must all work together to develop safe, effective, and affordable vaccines, treatments and tests that can be produced quickly and made available for the most vulnerable. Making this happen is possible through international collaboration.

The One19 campaign is making the argument about access for the most vulnerable around the world. Ensuring that the most vulnerable have access to vaccines, treatments and tests is the only way in which we can effectively save lives. It is the only way in which the global economy can recover and the only way to reopen our communities, societies and the world.

To have the greatest impact in slowing the virus’s spread, and bringing it under control internationally, every country needs access to vaccines, treatments and tests as quickly as possible.


Global COVID-19 data

To have the greatest impact in slowing the virus’ spread, and bring it under control internationally, we need global access to vaccines for the most vulnerable populations – as quickly as possible.

The rapid development and distribution of easy, accurate and rapid tests is critical to preventing and controlling the virus globally.

This pillar is co-convened by The Global Fund and FIND. It is focused on sourcing 2–3 high-quality rapid tests, training 10,000 healthcare professionals across 50 countries and establishing testing for 500 million people in Low and Middle-Income countries by mid-2021.

Treatments are not just a contingency until a vaccine is developed. Effective treatments could be a gamechanger in the fight against coronavirus – from helping patients fight the virus by lessening the severity of infection, to reducing the pressure on global healthcare systems and economies. Progress has already been made with corticosteroids that have been found to reduce the risk of mortality in patients with severe Covid-19.


Working together, we have a chance at making vaccines, treatments and tests available for the world's most vulnerable.


March 12, 2021 • GAVI

COVAX Vaccine Roll Out

Nigeria, Rwanda and Kenya have all started COVID-19 vaccination campaigns following the delivery of COVAX doses. Health and front line workers across the three countries will now start receiving vaccines after launch events this morning in Abuja, Kigali and Nairobi.

Read more >
WHO Vaccines explained

March 1, 2021 • WHO

Vaccines explained

A series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.

Read more >

About the campaign

One19 is a campaign led by the UK government. Concerted international action is the only way for us to end the pandemic. We must make sure that no country is left behind in the fight against Covid-19. The UK is proud to provide £548 million for COVAX, which will help supply at least 1.3 billion Covid-19 vaccine doses for up to 92 developing countries this year. All the material produced by Our World in Data, including interactive visualisations and code, are completely open access under the Creative Commons BY license.

ONE19 Partners


ONE19 Partners


WHO’s primary role is to direct international health within the United Nations’ system and to lead partners in global health responses.

Visit website

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines

Visit website

The Access to COVID-19 Tools (ACT) Accelerator, is a new, groundbreaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines

Visit website